NSCLC STAGE IIIB

Clinical trials for NSCLC STAGE IIIB explained in plain language.

Never miss a new study

Get alerted when new NSCLC STAGE IIIB trials appear

Sign up with your email to follow new studies for NSCLC STAGE IIIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1 Terminated 1

New drug cocktail shows promise for Hard-to-Treat lung cancer

Disease control Completed

This phase 2 trial tested a combination of chemotherapy (carboplatin or cisplatin plus pemetrexed) and immunotherapy (atezolizumab, with or without bevacizumab) in 150 people with advanced non-squamous non-small cell lung cancer that has EGFR, ALK, or ROS1 mutations and has progr…

Matched conditions: NSCLC STAGE IIIB

Phase: PHASE2 • Sponsor: Centre Francois Baclesse • Aim: Disease control

Last updated Jun 27, 2026 12:31 UTC

NSCLC STAGE IIIB

Get alerted when new NSCLC STAGE IIIB trials appear

New drug cocktail shows promise for Hard-to-Treat lung cancer